Subject: FBCD Explodes on SCV Coverage CNAB Rebounds Again

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
FBCD Explodes on SCV Coverage CNAB Rebounds Again
Hot Stock to WatchHot Stock to Watch

Company: FBC Holding, Inc. (Pink Sheets: FBCD)


Price: 0.0004

Change (%): + 0.0001 (33.33)

Volume: 99,437,955
FBCD Chart

FBC Holding, Inc. Announces 55% Increase in Leigh Valentine Product Sales for November

NEW YORK, Dec. 4, 2014 /PRNewswire/ - International product and development company, FBC Holding, Inc. (OTC: FBCD) and its cosmetics arm, Leigh Valentine have announced November sales for this year have increased a dramatic 55% over 2013.

Frank Russo, CEO of FBC Holding, Inc., stated, “Already the company has seen substantial return from its initial efforts. We knew that the Leigh Valentine brand had value in the market and we are thrilled with these results. Currently, we’re preparing to bring Leigh Valentine back into the market for 2015. Executing this strategy is critical and having new and exciting product line extensions for consumers is very exciting.”

Continue Reading

Company: United Cannabis Corp. (OTCQB: CNAB)


Price: 0.67

Change (%): + 0.0999 (17.52)

Volume: 42,673
CNAB Chart

About United Cannabis Corporation

United Cannabis Corporation was founded to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution, designed to enable physicians and patients to design, implement and monitor effective therapy protocols.

For further information, please visit

Company Information Sheet

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks